Cytokinetics announces three aficamten presentations at HCMS Scientific Sessions
CYTK•Cytokinetics will present two late-breaking oral presentations and one poster on aficamten at the Hypertrophic Cardiomyopathy Medical Society Scientific Sessions in Chicago on Nov. 6, 2026.
1. Three presentations planned
The two oral presentations will examine aficamten’s effects on cardiac structure, function and patient-reported health status in nonobstructive hypertrophic cardiomyopathy. A poster will address left ventricular systolic dysfunction during long-term aficamten therapy for obstructive hypertrophic cardiomyopathy.
